Akihiro Tomoyasu
Direttore/Membro del Consiglio presso KRINGLE PHARMA, INC.
Profilo
Akihiro Tomoyasu currently works at Kringle Pharma, Inc., as Director from 2016, KinoPharma, Inc., as Director from 2015, PharmaBio Corp., as Outside Director from 2020, HuLA immune, Inc., as Director, GenAhead Bio, Inc., as Outside Director from 2018, and MyMetagenome Co. Ltd., as Director from 2016.
Posizioni attive di Akihiro Tomoyasu
| Società | Posizione | Inizio |
|---|---|---|
| KRINGLE PHARMA, INC. | Direttore/Membro del Consiglio | 01/12/2016 |
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Direttore/Membro del Consiglio | 01/02/2019 |
| GenAhead Bio, Inc. | Direttore/Membro del Consiglio | 01/07/2018 |
| MyMetagenome Co. Ltd. | Direttore/Membro del Consiglio | 01/02/2016 |
KinoPharma, Inc.
 KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | 01/12/2015 |
PharmaBio Corp.
 PharmaBio Corp. BiotechnologyHealth Technology PharmaBio Corp. provides manufacturing and consulting company specializing in cellular and tissue based products. It offers of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment. The company was founded in April 1978 and is headquartered in Nagoya, Japan. | Direttore/Membro del Consiglio | 01/12/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KRINGLE PHARMA, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
KinoPharma, Inc.
KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Health Technology |
PharmaBio Corp.
PharmaBio Corp. BiotechnologyHealth Technology PharmaBio Corp. provides manufacturing and consulting company specializing in cellular and tissue based products. It offers of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment. The company was founded in April 1978 and is headquartered in Nagoya, Japan. | Health Technology |
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Health Technology |
| GenAhead Bio, Inc. | |
| MyMetagenome Co. Ltd. |
- Borsa valori
- Insiders
- Akihiro Tomoyasu
